Joseph Landolina

Executive Officer, Director at Cresilon.

Raised on Cresilon filings

$29M

of $29M offered across 2 Form D filings

Company

Biotech · Brooklyn, NY

Plant-based gel that stops severe bleeding

Plant-based gel that stops severe bleeding

Cresilon Form D filings
Filed	Security	Sold of offered	Filing
Jun 26, 2026	Debt	$29M/ $29M	Form D/A
Apr 29, 2026	Debt	$5M/ $25M	Form D

Also named on Cresilon filings